{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:29Z","timestamp":1794047489590,"version":"4.8.0"},"reference-count":13,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"2","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2024.285531","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T11:08:44Z","timestamp":1727953724000},"page":"493-497","source":"Crossref","is-referenced-by-count":5,"title":["Evaluating serum free light chain ratio as a biomarker in multiple myeloma"],"prefix":"10.3324","volume":"110","author":[{"given":"Theresia","family":"Akhlaghi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylee","family":"Maclachlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Korde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sham","family":"Mailankody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lesokhin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Hassoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney X.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhwani","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urvi","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlyn","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriy","family":"Derkach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Lahoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather J.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunjan L.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Scordo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio A.","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad Z.","family":"Usmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Hultcrantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"72418","doi-asserted-by":"crossref","unstructured":"Rajkumar SV, Dimopoulos MA, Palumbo A. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014; 15(12):e538-e548.","DOI":"10.1016\/S1470-2045(14)70442-5"},{"key":"72419","doi-asserted-by":"crossref","unstructured":"Kastritis E, Terpos E, Moulopoulos L. Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease. Leukemia. 2013; 27(4):947-953.","DOI":"10.1038\/leu.2012.309"},{"key":"72420","doi-asserted-by":"crossref","unstructured":"Larsen JT, Kumar SK, Dispenzieri A. Serum free light chain ratio as a biomarker for high-risk smoldering multiple myeloma. Leukemia. 2013; 27(4):941-946.","DOI":"10.1038\/leu.2012.296"},{"key":"72421","doi-asserted-by":"crossref","unstructured":"Dispenzieri A, Kyle RA, Katzmann JA. Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma. Blood. 2008; 111(2):785-789.","DOI":"10.1182\/blood-2007-08-108357"},{"key":"72422","doi-asserted-by":"crossref","unstructured":"S\u00f8rrig R, Klausen TW, Salomo M. Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study. Eur J Haematol. 2016; 97(3):303-309.","DOI":"10.1111\/ejh.12728"},{"key":"72423","doi-asserted-by":"crossref","unstructured":"Wu V, Moshier E, Leng S. Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling. Blood Adv. 2018; 2(12):1470-1479.","DOI":"10.1182\/bloodadvances.2018016998"},{"key":"72424","doi-asserted-by":"crossref","unstructured":"Visram A, Rajkumar SV, Kapoor P. Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio \u2265100. Leukemia. 2022; 36(5):1429-1431.","DOI":"10.1038\/s41375-022-01529-w"},{"key":"72425","doi-asserted-by":"crossref","unstructured":"Lakshman A, Vincent Rajkumar S, Buadi FK. Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria. Blood Cancer J. 2018; 8(6):59.","DOI":"10.1038\/s41408-018-0077-4"},{"key":"72426","doi-asserted-by":"crossref","unstructured":"Waxman AJ, Mick R, Garfall AL. Classifying ultra-high risk smoldering myeloma. Leukemia. 2015; 29(3):751-753.","DOI":"10.1038\/leu.2014.313"},{"key":"72427","doi-asserted-by":"crossref","unstructured":"Oben B, Froyen G, Maclachlan KH. Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities. Nat Commun. 2021; 12(1):1861.","DOI":"10.1038\/s41467-021-22140-0"},{"key":"72428","doi-asserted-by":"crossref","unstructured":"Boyle EM, Deshpande S, Tytarenko R. The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma. Nat Commun. 2021; 12(1):293.","DOI":"10.1038\/s41467-020-20524-2"},{"key":"72429","doi-asserted-by":"crossref","unstructured":"Bustoros M, Sklavenitis-Pistofidis R, Park J. Genomic profiling of smoldering multiple myeloma identifies patients at a high risk of disease progression. J Clin Oncol. 2020; 7(21):2380-2389.","DOI":"10.1200\/JCO.20.00437"},{"key":"72430","doi-asserted-by":"crossref","unstructured":"Akhlaghi T, Nemirovsky D, Maclachlan K. Evaluating the effect of evolving changes in serum biomarkers on the risk of progression in smoldering multiple myeloma. Blood. 2023; 142(Suppl 1):877.","DOI":"10.1182\/blood-2023-180315"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285531\/77609","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285531\/78046","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11772\/77609","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:07:23Z","timestamp":1794046043000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.285531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.285531","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,3]]}}}